Rennova Health, Inc. (NASDAQ: RNVA), Florida-based provider of technologies and services to the healthcare industry, has successfully faced a number of industry-wide challenges in recent years due to the steadfast focus on strict compliance by its executive team and the resulting potential that approach offers toward expanding provider contracts. It’s an accomplishment based upon a blend of industry knowledge and a sound approach to management and finance.

• Thomas Mika (Chairman) – With an MBA from Harvard and an undergraduate degree in Microbiology, Mr. Mika has held a number of executive positions in the healthcare and other technology industries, and has an extensive background in building healthcare and software companies. He is Chairman, President, and Acting CFO of healthcare data analytics company CollabRx, which merged with Rennova in November 2015. Earlier he was President and Chief Executive Officer of Tegal Corporation, becoming Chairman of the Board the following year. At Tegal he had served as Executive Vice President, Chief Financial Officer, and was on the Board of Directors, managing the activities that led to the company’s IPO in 1995.
• Seamus Lagan (President, Chief Executive Officer, Director) – Mr. Lagan’s expertise includes over two decades in the restructuring, development, and management of both public and private companies. His guidance has been critical to the growth of Rennova Health, as well as to the company’s achieving an impressive NASDAQ listing. Mr. Lagan was initially approached to help in the development of new business opportunities for the company, and his efforts have supported the structuring of the company’s business plan as well as the securing of vital funding. Mr. Lagan has also served as the CEO of two principal subsidiaries of Medytox Solutions.
• Jason Adams (Chief Financial Officer) – Mr. Adams has held senior financial executive positions with Alico and Source Interlink Companies, and was the Chief Financial Officer of West Central Behavioral Health, a provider of mental health services to communities in New Hampshire.
• Sri Bharat Madireddy, PhD (COO of Medytox Diagnostics, CEO of Rennova owned Laboratories) – Dr. Madireddy serves Rennova as Technical Supervisor and Director LC-MSMS for Toxicology operations. He is Board Certified in Clinical Chemistry by the American Association of Bioanalysts, and has extensive experience in analytical chemistry and toxicology.

For more information, visit www.RennovaHealth.com